Effect of higher dose of vitamin D supplementation in control of disease activity in SLE
Not Applicable
- Conditions
- Health Condition 1: M321- Systemic lupus erythematosus withorgan or system involvement
- Registration Number
- CTRI/2019/06/019658
- Lead Sponsor
- Department of Biotechnology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 172
Inclusion Criteria
SLE diagnosed on basis of SLICC criteria
SLEDAI less or equal to 8
Exclusion Criteria
pregnancy, lactation, cancer, hypercalcemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in SLEDAI scoreTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method Change in anti-dsDNA and IFN-alpha levelTimepoint: 6 and 12 months;Frequency of flareTimepoint: over 12 months